FibroGen Inc (NASDAQ: FGEN) Stock Information | RedChip

FibroGen Inc (NASDAQ: FGEN)


$0.4963
-0.0023 ( -0.74% ) 2.2M

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Market Data


Open


$0.4963

Previous close


$0.4986

Volume


2.2M

Market cap


$50.24M

Day range


$0.4680 - $0.5690

52 week range


$0.1800 - $2.9300

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Dec 18, 2024
8-k 8K-related 14 Dec 16, 2024
4 Insider transactions 1 Dec 09, 2024
4 Insider transactions 1 Dec 09, 2024
4 Insider transactions 1 Dec 09, 2024
8-k 8K-related 12 Nov 12, 2024
10-q Quarterly Reports 76 Nov 12, 2024
8-k 8K-related 11 Oct 03, 2024
8-k 8K-related 11 Sep 16, 2024
8-k 8K-related 11 Sep 13, 2024

Latest News